Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
VIDEO: Addressing disparities in obesity care
In this video, Katherine Saunders, MD, DABOM, discusses the need for clinicians who are "culturally competent" and provide evidence-based, comprehensive obesity treatment.
VIDEO: Expert discusses collaboration between obesity medicine physicians, PCPs
In this video, Katherine Saunders, MD, DABOM, emphasizes the need for obesity medicine physicians and primary care physicians to work together on a patient's treatment.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Importance of personalized, multifactorial treatment plans for patients with obesity
In this video, Katherine Saunders, MD, DABOM, describes the thorough evaluation of each obesity patient to create a treatment plan tailored to their specific needs.
VIDEO: Lifestyle intervention critical for obesity prevention, treatment
In this video, Katherine Saunders, MD, DABOM, discusses factors that may contribute to weight gain and how physicians can address and manage these factors, even prior to a patient gaining weight.
Understand bitcoin as a store of value: A guide for physicians
In the rapidly evolving landscape of investments, it is crucial for physicians to stay informed about alternative asset classes, such as cryptocurrency.
Low bone mineral density score may predict risk for liver cirrhosis
Low bone mineral density may be a risk factor for developing cirrhosis, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.
Combined insomnia, OSA phenotype predicts incident diabetes in men
In older men, the sleep breathing impairment index definition of combined insomnia-obstructive sleep apnea predicted incident diabetes, according to results published in Annals of the American Thoracic Society.
Olezarsen reduces triglycerides, pancreatitis events in familial chylomicronemia syndrome
Monthly olezarsen 80 mg significantly lowered triglyceride levels and also reduced incidence of acute pancreatitis vs. placebo in patients with familial chylomicronemia syndrome, according to a study in The New England Journal of Medicine.
Fully-implantable CGM receives FDA authorization for integration with insulin pumps
The FDA granted integrated continuous glucose monitoring designation to a fully-implantable CGM, according to a press release.
'We have to tailor the treatment' for obesity in children and adolescents
DENVER — Individualized care is critical for treating childhood obesity, according to a presenter at the Obesity Medicine Association’s annual conference.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read